Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014005
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institute that offers technologies to improve human health. The institute undertakes the development of therapies for diseases that include alzheimer’s, parkinson’s, diabetes and other cancers. It provides programs in developmental biology, stem cell research, cancer research, immunology, regenerative medicine, genetics and genomics-programs. Whitehead has affiliation with Massachusetts Institute of Technology in its teaching activities to provide intellectual, collegial and scientific benefits of the research university. Whitehead Institute is headquartered in Cambridge, Massachusetts, the US.

Whitehead Institute for Biomedical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 10
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 11
White Head Institute And Biogen Idec Enter Into Reasearch Agreement 12
Licensing Agreements 13
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 13
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 14
Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 16
Whitehead Institute for Biomedical Research – Key Competitors 17
Whitehead Institute for Biomedical Research – Key Employees 18
Whitehead Institute for Biomedical Research – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Dec 26, 2016: Naturally occurring mechanism of cancer drug-resistance may itself be a treatment target 21
Feb 18, 2016: B-cell diversity in immune system’s germinal centers may be key to broad-spectrum vaccines 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Key Facts 2
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Whitehead Institute for Biomedical Research, Deals By Therapy Area, 2011 to YTD 2017 8
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 10
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 11
White Head Institute And Biogen Idec Enter Into Reasearch Agreement 12
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 13
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 14
Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 16
Whitehead Institute for Biomedical Research, Key Competitors 17
Whitehead Institute for Biomedical Research, Key Employees 18

★海外企業調査レポート[Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • ReShape Medical Inc-医療機器分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務分析
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • C.A. Curtze Co. Inc.:企業の戦略・SWOT・財務分析
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hydro-Electric Corporation:電力:M&Aディール及び事業提携情報
    Summary Hydro-Electric Corporation (Hydro Tasmania) is a state owned integrated energy utility. It generates electricity and supplies that on wholesale and retail basis. The company produces power using hydro, gas, wind and solar sources. Hydro Tasmania also retails gas to business and residential c …
  • Coor Service Management Holding AB:企業の戦略・SWOT・財務情報
    Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report Summary Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Oneida Ltd.:企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Brunel International NV (BRNL):企業の財務・戦略的SWOT分析
    Brunel International NV (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • University of Southampton:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Southampton (UOS) is an educational institution that offers education and research services. The institute provides educational programs in the fields of accounting and finance, acoustical engineering, aeronautics and astronautics, anthropology, archaeology, biochemistry, biolo …
  • e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析
    e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • TeleTech Holdings, Inc. (TTEC):企業の財務・戦略的SWOT分析
    TeleTech Holdings, Inc. (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • TOWER Limited:企業の戦略・SWOT・財務情報
    TOWER Limited - Strategy, SWOT and Corporate Finance Report Summary TOWER Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pathway Genomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pathway Genomics Corp (Pathway Genomics) is a healthcare laboratory that offers genetic testing services. Its tests comprise liquid biopsy cancer intercept, true hereditary cancer genetic tests, DNA insight general health and wellness genetic tests, DNA insight pharmacogenomics tests, and ca …
  • Public Power Corporation SA (PPC):企業の財務・戦略的SWOT分析
    Public Power Corporation SA (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China Aviation Oil (Singapore) Corp Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corp Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Icelandair Group:戦略・SWOT・企業財務分析
    Icelandair Group - Strategy, SWOT and Corporate Finance Report Summary Icelandair Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆